Development of pyrimidine-based inhibitors of Janus tyrosine kinase 3.

2006 
A new class of pyrimidine-based Janus tyrosine kinase 3 (JAK3) inhibitors are described. Many of these inhibitors showed low nanomolar activity against JAK3.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    8
    References
    34
    Citations
    NaN
    KQI
    []